Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule
BioSpace
Tue, 11/7/23 - 10:05 am
Tags:
Novartis, Chong Kun Dang Pharmaceutical, small molecule drugs
FDA approves Novartis Cosentyx as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade
Yahoo Finance
Wed, 11/1/23 - 10:14 pm
Tags:
Novartis, Cosentyx, FDA, hidrad
Atrasentan data backs up Novartis’ $3.5bn Chinook deal
Pharmaphorum
Mon, 10/30/23 - 10:21 am
Tags:
Novartis, IgA nephropathy, atrasentan, Chinook Therapeutics
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
Tags:
earnings, Bristol Myers Squibb, Takeda, Novartis, Sanofi, Merck
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
Thu, 10/26/23 - 10:52 pm
Tags:
Novartis, Takeda, trade secrets
Novartis Beats Earnings Estimate in Q3, Raises Full-Year Guidance
BioSpace
Tue, 10/24/23 - 07:46 pm
Tags:
Novartis, earnings
Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data
BioSpace
Tue, 10/24/23 - 09:54 am
Tags:
ESMO, Novartis, prostate cancer, Pluvicto, radiopharmaceuticals
Novartis expats detail their health-tech spinoff DatosX
Medical Marketing and Media
Wed, 10/11/23 - 11:44 pm
Tags:
Novartis, innovation, digital health, spinoffs, DatosX
Novartis cuts depression study, nearly erasing $210M Cadent acquisition from pipeline
Fierce Biotech
Tue, 10/10/23 - 11:36 am
Tags:
Novartis, Cadent Therapeutics, major depressive disorder, MIJ821
Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A
Fierce Biotech
Mon, 10/9/23 - 11:12 am
Tags:
AstronauTx, Novartis, Alzheimer's disease
Novartis Wins FDA Approval for Intravenous Cosentyx Formulation
BioSpace
Mon, 10/9/23 - 10:14 am
Tags:
Novartis, Cosentyx, FDA, ankylosing spondylitis, psoriatic arthritis, non-radiographic axial spondyloarthritis
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters
Wed, 10/4/23 - 09:43 am
Tags:
Novartis, Sandoz, spinoffs
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Clinical Trials Arena
Mon, 10/2/23 - 10:14 am
Tags:
Novartis, clinical trials, iptacopan, IgA nephropathy, kidney disease
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Tags:
Adlai Nortye, IPOs, Novartis, AN2025, head and neck cancer, solid tumors
Novartis confirms Sandoz spin-off for October 4, 2023
Reuters
Mon, 09/25/23 - 07:45 pm
Tags:
Novartis, Sandoz, spinoffs
Novartis eyes first-line use of Lutathera after trial win
Pharmaphorum
Mon, 09/25/23 - 11:41 am
Tags:
Novartis, radioligands, clinical trials, neuroendocrine tumors, Lutathera
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
BioSpace
Sun, 09/24/23 - 08:52 pm
Tags:
FDA, ARS Pharmaceuticals, Novartis, Taysha, Alvotech, Intarcia
Novartis hit with another serious drug marketing breach, this time for multiple sclerosis therapy Mayzent
Fierce Pharma
Thu, 09/21/23 - 10:36 am
Tags:
Novartis, UK, PMCPA, pharma marketing, Mayzent
BeiGene to go solo with cancer drug after Novartis deal termination
Yahoo/Reuters
Tue, 09/19/23 - 10:30 am
Tags:
BeiGene, Novartis, cancer, tislelizumab, Tivimbra
Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Tags:
Bausch + Lomb, Novartis, M&A, Xiidra

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.